KJIM :: Korean Journal of Internal Medicine

Traditional Chinese medicine for the treatment of immune-related nephropathy: A review

Acta Pharmaceutica Sinica B.2024; 14(1): 38. CrossRef

Assessing the Effects of Modern Renoprotective Agents in Preventing Progression of Renal Composite Outcomes in Patients with Type 2 Diabetes: A Network Meta-analysis

ENSMUST00000147869 regulates proliferation and fibrosis of mesangial cells in diabetic nephropathy by interacting with Hspa9

Min Wang, Xin Chen, Henglu Zhang, Lanlan Li, Yang Xu, Weiping Lu, Yibing Lu

Glomerular filtration rate as a kidney outcome of diabetic kidney disease: a focus on new antidiabetic drugs

The Korean Journal of Internal Medicine.2022; 37(3): 502. CrossRef

Therapeutic effect of kidney tubular cells-derived conditioned medium on the expression of microRNA-377, Microrna-29a, aquapurin-1, biochemical, and histopathological parameters following diabetic nephropathy injury in rats

Esrafil Mansouri, Mahmoud Orazizadeh, SeyyedAli Mard, Armita Valizadeh Gorji, Mohammad Rashno, Fereshtesadat Fakhredini

Advanced Biomedical Research.2022; 11(1): 119. CrossRef

Tratamiento renal sustitutivo con diálisis en el paciente diabético

Marina Blanco-García, Susana Aránega-Gavilán, Irene Guillén-Gómez, Rodolfo Crespo-Montero

Enfermería Nefrológica.2022; 25(4): 300. CrossRef

Severe hypoglycemia and the risk of end stage renal disease in type 2 diabetes

Jae-Seung Yun, Yong-Moon Park, Kyungdo Han, Hyung-Wook Kim, Seon-Ah Cha, Yu-Bae Ahn, Seung-Hyun Ko

Is there a relationship between the prevalence of autoimmune thyroid disease and diabetic kidney disease?

Magdalena Maria Stefanowicz-Rutkowska, Wojciech Matuszewski, Katarzyna Gontarz-Nowak, Elżbieta Maria Bandurska-Stankiewicz

The effect of isosorbide-mononitrate on proteinuria in patients with diabetic nephropathy

Journal of Surgery and Medicine.2021; 5(6): 620. CrossRef

Diabetic Nephropathy: Challenges in Pathogenesis, Diagnosis, and Treatment

BioMed Research International.2021; 2021: 1. CrossRef

Changing the Concept: From the Traditional Glucose-centric to the New Cardiorenal-metabolic Approach for the Treatment of Type 2 Diabetes

Dimitrios G Chatzis, Konstantinos Kolokathis, Kalliopi Magounaki, Stefanos Chatzidakis, Konstantinos Avramidis, Marianna Leopoulou, Theodoros P Angelopoulos, John Doupis

touchREVIEWS in Endocrinology.2021; 17(2): 92. CrossRef

Особливості перебігу діабетичної хвороби нирок у хворих на латентний автоімунний діабет дорослих

INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (Ukraine).2021; 17(2): 116. CrossRef

Keap1/Nrf2/ARE signaling unfolds therapeutic targets for redox imbalanced-mediated diseases and diabetic nephropathy

Temitope Isaac Adelusi, Lei Du, Meng Hao, Xueyan Zhou, Qian Xuan, Chowdhury Apu, Ying Sun, Qian Lu, Xiaoxing Yin

Biomedicine & Pharmacotherapy.2020; 123: 109732. CrossRef

A Novel Indoline Derivative Ameliorates Diabesity-Induced Chronic Kidney Disease by Reducing Metabolic Abnormalities

Anna Permyakova, Asaad Gammal, Liad Hinden, Michal Weitman, Marta Weinstock, Joseph Tam

Jowiseungki decoction affects diabetic nephropathy in mice through renal injury inhibition as evidenced by network pharmacology and gut microbiota analyses

Xianglong Meng, Junnan Ma, Seok Yong Kang, Hyo Won Jung, Yong-Ki Park

DACH1, a novel target of miR-218, participates in the regulation of cell viability, apoptosis, inflammatory response, and epithelial-mesenchymal transition process in renal tubule cells treated by high-glucose

Ying-Li Zhang, Jie-Min Wang, Hong Yin, Shou-Bao Wang, Cai-Ling He, Jing Liu

Therapeutic application of nutraceuticals in diabetic nephropathy: Current evidence and future implications

Ehsan Dehdashtian, Mohammad Hossein Pourhanifeh, Karim Hemati, Saeed Mehrzadi, Azam Hosseinzadeh

Diabetes/Metabolism Research and Reviews.2020;[Epub] CrossRef

RIPK3 blockade attenuates tubulointerstitial fibrosis in a mouse model of diabetic nephropathy

Ying Shi, Chunling Huang, Yongli Zhao, Qinghua Cao, Hao Yi, Xinming Chen, Carol Pollock

Elias A. T. Koch, Rola Nakhoul, Farid Nakhoul, Nakhoul Nakhoul

International Urology and Nephrology.2020; 52(9): 1705. CrossRef

Diabetic nephropathy: An update on pathogenesis and drug development

Vikram Rao A/L B Vasanth Rao, Sean Hong Tan, Mayuren Candasamy, Subrat Kumar Bhattamisra

Diabetes & Metabolic Syndrome: Clinical Research & Reviews.2019; 13(1): 754. CrossRef

Adiponectin for the treatment of diabetic nephropathy

Jun Young Lee, Jae Won Yang, Byoung Geun Han, Seung Ok Choi, Jae Seok Kim

The Korean Journal of Internal Medicine.2019; 34(3): 480. CrossRef

Comparing the Effect of Dipeptidyl-Peptidase 4 Inhibitors and Sulfonylureas on Albuminuria in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A Prospective Open-Label Study

Po-Chung Cheng, Shang-Ren Hsu, Jeng-Fu Kuo, Yun-Chung Cheng, Yu-Hsiu Liu, Shih-Te Tu

Journal of Clinical Medicine.2019; 8(10): 1715. CrossRef

Lipid mediators of insulin signaling in diabetic kidney disease

American Journal of Physiology-Renal Physiology.2019; 317(5): F1241. CrossRef

Changes in co-morbidity pattern in patients starting renal replacement therapy in Europe—data from the ERA-EDTA Registry

Maria L Ceretta, Marlies Noordzij, Rosario Luxardo, Johan De Meester, Jose M Abad Diez, Patrik Finne, James G Heaf, Cécile Couchoud, Reinhard Kramar, Frederic Collart, Aleix Cases, Runolfur Palsson, Anna V Reisæter, Helena Rydell, Ziad A Massy, Kitty J Ja

Nephrology Dialysis Transplantation.2018; 33(10): 1794. CrossRef

AGE-RAGE axis blockade in diabetic nephropathy: Current status and future directions

Davoud Sanajou, Amir Ghorbani Haghjo, Hassan Argani, Somayeh Aslani

European Journal of Pharmacology.2018; 833: 158. CrossRef